News

Household contacts drive over half of all infant hepatitis B exposures, challenging selective neonatal vaccination recommendations.

A four-month tuberculosis treatment regimen showed comparable efficacy and safety to standard six-month therapy in selected patients.

Retatrutide significantly reduced nighttime breathing disruptions in adults with obstructive sleep apnea across two randomized clinical trials.

Initiating pediatric HPV vaccination at ages 9–10 significantly accelerates adolescent series completion rates before age thirteen.

Early relapse within three months following definitive therapy dramatically reduces long-term survival in oral tongue cancer.

Intraputaminal stem cell therapy demonstrates 12-month safety, survival, and clinical motor stabilization in moderate Parkinson’s disease.

Antimicrobial resistance was linked to $3.5 trillion in global economic losses in 2021, new research reveals.

A shared metabolic pathway may drive airway damage and persistent bacterial infections in people with cystic fibrosis.